Showing 941 - 960 results of 30,886 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 0.76s Refine Results
  1. 941
  2. 942
  3. 943
  4. 944
  5. 945
  6. 946
  7. 947
  8. 948

    Pain duration dependent decrease in cognitive performance. by Marijtje L. A. Jongsma (208906)

    Published 2011
    “…The mean of the scores of the controls (with pain duration zero) on each of the nine tests was taken as 100%. For those test where an increase in test score indicated a decrease in performance, the inverse of the raw scores was taken. …”
  9. 949
  10. 950
  11. 951
  12. 952

    SMNΔ7 NMJs display a decrease in synaptic efficacy. by Karen K. Y. Ling (237660)

    Published 2010
    “…There is an increase in MEPP amplitude, a decrease in MEPP frequency and a reduction in quantal content in SMNΔ7 mice (n = 100–130 NMJs from 7 control and 10 SMNΔ7 mice; ***<i>p</i><0.0001, ** <i>p</i> = 0.007). …”
  13. 953
  14. 954
  15. 955
  16. 956
  17. 957

    Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer by Ana Alfaro (280118)

    Published 2016
    “…Here, we investigated the association between different HPV16 variants and early (≤ 49 years) or delayed (≥ 50 years) CC presentation. …”
  18. 958

    GBE decreased secretion of Aβ1-40 in APP cells. by Virginie Rhein (243241)

    Published 2010
    “…Secreted Aβ1-40 was significantly decreased in GBE-treated APP cells (100 µg/ml; 24 h). …”
  19. 959

    SDF-1β significantly increases key autophagy markers and decreases apoptotic markers during H<sub>2</sub>O<sub>2</sub>-induced cell death. by Samuel Herberg (585126)

    Published 2013
    “…Densitometry quantification of immunoreactive bands revealed that SDF-1β significantly increased the normalized levels of C) intact PARP, decreased the levels of D) cleaved PARP and E) cleaved caspase-3, and increased the levels of F) beclin 1 and G) LC3B-II in Tet-Off-SDF-1β BMSCs in response to H<sub>2</sub>O<sub>2</sub> treatment compared to Dox-suppressed and Tet-Off-EV controls (6 h, ±100 ng/ml Dox, ±1.0 mM H<sub>2</sub>O<sub>2</sub>, ***p<0.0001, −Dox; H<sub>2</sub>O<sub>2</sub> vs. …”
  20. 960